Since the 1990s, several reports have suggested that analysis of PSA kinetics prior to PCa diagnosis could predict tumor grade, stage, and time to disease recurrence following radical prostatectomy (RP)4–6. The gene discussed is KLK3; the disease is posterior cortical atrophy.